Sponsor:
Roswell Park Cancer Institute
Code:
NCT06206863
Conditions
Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Exercise Intervention
Questionnaire Administration
Brief summary:
Conditions
Hematopoietic and Lymphoid System Neoplasm
Malignant Solid Neoplasm
Study ID
NCT06206863
Start date
Aug 20, 2024
Status verified date
Jul, 2026
Completion date
Dec 30, 2027
Anticipated
Primary completion date
Dec 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
200 participants
Anticipated
Intervention Model
Single group
Primary purpose
Supportive Care
Arms
experimental: Supportive Care (virtual exercise classes)
Interventions
Exercise Intervention
Questionnaire Administration
Primary outcome measure
Locations
Roswell Park Cancer Institute
Recruiting
Buffalo, New York, United States, 14263
Contacts
Principal Investigator:
Andrew D. Ray
Sponsor
Roswell Park Cancer Institute
Last update posted
Jul 29, 2026
Last verified
Jul, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Roswell Park Cancer Institute on 2026-07-29.